text: Uppsala University

text: live

text: Generic

text: Ostrich samples from Sahlins struts, Borlange, Sweden. Preserved brain and liver tissues in RNAlater (Qiagen, Hilden, Germany). This sample contains pooled RNA from male brain tissue, individual: 16 and 21

text: Struthio camelus

text: Absence of dosage compensation and the arrested stage of sex chromosome evolution in ostriches: BM2


Delta-hos2 H3K9ac (first run)

status: PUBLIC

characteristic: External Id

text: Weizmann Institute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: The ChIP-Seq experiments were done on BY4741 strains, with 9 different ORF (HOS2, SET3, SAP30, PHO23, RPD3, BRE1, RAD6, UBP8, UBP10) replaced with KANMX cassette. Chromatin immuno-precipitation was done as described previously (Liu et al., 2005), with some modifications. Samples were sonicated with bioruptor sonicator for 60 minutes (30 sec intervals), and were precipitated with H3K9-acetyl antibody (Abcam ab12179) and conjugated to protein A beads. High throughput sequencing was done using Illumina GAII system in the department of biological services, Weizmann Institute of science, Israel.

characteristic: description

text: Saccharomyces cerevisiae S288C

characteristic: organism

text: Delta-hos2 H3K9ac (first run)

characteristic: title


Delta-rpd3 H3K9ac (first run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-rpd3 H3K9ac (first run)


Delta-sap30 H3K9ac (first run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-sap30 H3K9ac (first run)


Delta-pho23 H3K9ac (first run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-pho23 H3K9ac (first run)


wt H3K9ac (first run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: wt H3K9ac (first run)


Delta-bre1 H3K9ac (second run)

text: Weizmann Institute

text: live

text: Generic

text: The ChIP-Seq experiments were done on BY4741 strains, with 9 different ORF (HOS2, SET3, SAP30, PHO23, RPD3, BRE1, RAD6, UBP8, UBP10) replaced with KANMX cassette. Chromatin immuno-precipitation was done as described previously (Liu et al., 2005), with some modifications. Samples were sonicated with bioruptor sonicator for 60 minutes (30 sec intervals), and were precipitated with H3K9-acetyl antibody (Abcam ab12179) and conjugated to protein A beads. High throughput sequencing was done using Illumina GAII system in the department of biological services, Weizmann Institute of science, Israel. Multiplex PCR was used to verify enrichment of DNA that binds acetylated histones. Samples from 4 deletion strains (?Bre1, ?Rad6, ?Ubp8, ?Ubp10) and WT were labeled with barcodes and sequenced in the same lane. The other samples were sequenced at separate lanes.

text: Saccharomyces cerevisiae S288C

text: Delta-bre1 H3K9ac (second run)


Delta-rad6 H3K9ac (second run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-rad6 H3K9ac (second run)


Delta-ubp8 H3K9ac (second run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-ubp8 H3K9ac (second run)


text: Institute for Genome Sciences University of MD School of Medicine

text: live

text: Generic

text: Escherichia coli BCE006_MS-23

tag: attribute

characteristic: strain

text: Escherichia coli BCE006_MS-23


Delta-ubp10 H3K9ac (second run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: Delta-ubp10 H3K9ac (second run)


wt H3K9ac (second run)

text: Weizmann Institute

text: live

text: Generic

text: Saccharomyces cerevisiae S288C

text: wt H3K9ac (second run)


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

characteristic: rna subset

text: vegetative strain ALXC2

text: vegetative

characteristic: stage


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: vegetative strain ALXC9

text: vegetative


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: mating 24hr post-mixing

text: mating 24hr post-mixing


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: mating 30hr post-mixing

text: mating 30hr post-mixing


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: mating 48hr post-mixing

text: mating 48hr post-mixing


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: mating 55hr post-mixing

text: mating 55hr post-mixing


text: Zahler Lab, MCD Biology, UC Santa Cruz

text: live

text: Generic

text: Oxytricha trifallax

text: small RNA

text: mating 72hr post-mixing

text: mating 72hr post-mixing


text: modENCODE DCC, Ontario Institute for Cancer Research

text: live

text: Generic

characteristic: cell line

text: late embryonic stage

characteristic: developmental stage

text: Drosophila melanogaster

text: G2 cells

text: embryo-derived cell-line

characteristic: tissue

text: G2 extraction1_seq1 aliquote 1


characteristic: External Id

characteristic: INSDC center name

text: live

text: Generic

text: late embryonic stage

text: mh

characteristic: genotype

text: Drosophila melanogaster

text: embryo-derived cell-line

text: S3 V074 (Replicate 1) extraction1_seq1 aliquote 1


characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: fGS/OSS

text: adult stage

text: Drosophila melanogaster

text: female

characteristic: sex

text: fGS/OSS cells

text: ovary

text: fGS/OSS extraction1_seq1 aliquote 1


text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: third instar larval stage

text: Drosophila melanogaster

text: CME_L1 cells

text: ventral prothoracic disc

text: CME_L1 extraction1_seq1 aliquote 1


text: live

text: Generic

text: late embryonic stage

text: Drosophila melanogaster

characteristic: organism

text: S1 cells

text: embryo-derived cell-line

text: S1 extraction1_seq1 aliquote 1

characteristic: title


text: live

text: Generic

text: OSC

text: adult stage

text: Drosophila melanogaster

text: female

text: OSC cells M031

text: ovary stem cells

text: OSC cells M031 extraction1_seq1 aliquote 1


text: live

text: Generic

text: Generic

characteristic: biosamplemodel

text: Homo sapiens

characteristic: taxon id

text: Chlamydia trachomatis E infected Homo sapiens Hela cells 8a_1_CtE_Hep2_rRNAdepl


text: Zavolan, Biozentrum, University of Basel

text: live

text: Generic

text: NUDT21 (2203C3)

characteristic: antibody

characteristic: antibody catalog number

characteristic: antibody lot number

text: Santa Cruz Biotechnology, Inc.

characteristic: antibody vendor

characteristic: cell line

text: 4-SU / 365 nm

characteristic: crosslinker and crosslinking wavelength

text: Homo sapiens

text: HEK293, CF Im25 CLIP

text: PAR-CLIP CF Im25


characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: monoclonal anti-FLAG M2

text: SIGMA

text: 4-SU / 365 nm

text: stably transformed to produce FLAG-tagged protein

characteristic: genotype/variation

text: Homo sapiens

text: HEK293, CF Im25 CLIP

text: PAR-CLIP CF Im25 rep B


characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: monoclonal anti-FLAG M2

text: SIGMA

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CF Im59 CLIP

text: PAR-CLIP CF Im59


text: live

text: Generic

characteristic: SRA accession

text: monoclonal anti-FLAG M2

text: SIGMA

text: 4-SU / 365 nm

text: Homo sapiens

characteristic: organism

text: HEK293, CF Im68 CLIP

text: PAR-CLIP CF Im68 rep B

characteristic: title


text: live

text: Generic

text: monoclonal anti-FLAG M2

characteristic: antibody

characteristic: antibody catalog number

text: SIGMA

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CF Im68 CLIP

text: PAR-CLIP CF Im68


text: live

text: Generic

text: CPSF4 (2202C1)

characteristic: antibody lot number

text: Santa Cruz Biotechnology, Inc.

characteristic: antibody vendor

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-30 CLIP

text: PAR-CLIP CPSF-30


text: live

text: Generic

text: monoclonal anti-FLAG M2

text: SIGMA

characteristic: cell line

text: 4-SU / 365 nm

characteristic: crosslinker and crosslinking wavelength

text: Homo sapiens

text: HEK293, CPSF-30 CLIP

text: PAR-CLIP CPSF-30 repB


characteristic: External Id

characteristic: INSDC center name

text: live

text: Generic

text: CPSF3 (T-20)

text: Santa Cruz Biotechnology, Inc.

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-73 CLIP

text: PAR-CLIP CPSF-73


characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: CPSF3 (T-20)

text: Santa Cruz Biotechnology, Inc.

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-73 CLIP

text: PAR-CLIP CPSF-73 rep B


characteristic: INSDC secondary accession

text: live

text: Generic

text: not commercial

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-100 CLIP

text: PAR-CLIP CPSF-100


text: live

characteristic: INSDC status

text: Generic

text: Bethyl

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-100 CLIP

text: PAR-CLIP CPSF-100 rep B


text: live

text: Generic

characteristic: NCBI submission model

text: CPSF1 (H-300)

text: Santa Cruz Biotechnology, Inc.

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-160 CLIP

text: PAR-CLIP CPSF-160


text: live

text: Generic

characteristic: NCBI submission package

text: Bethyl

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CPSF-160 CLIP

text: PAR-CLIP CPSF-160 rep B


text: live

text: Generic

characteristic: SRA accession

text: not commercial

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, Fip1 CLIP

text: PAR-CLIP Fip1


text: live

text: Generic

text: not commercial

text: 4-SU / 365 nm

text: Homo sapiens

characteristic: organism

text: HEK293, Fip1 CLIP

text: PAR-CLIP Fip1 rep B


text: live

text: Generic

text: CstF-64 (C-20)

text: Santa Cruz Biotechnology, Inc.

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CstF-64 CLIP

text: PAR-CLIP CstF-64

characteristic: title


text: live

text: Generic

text: monoclonal anti-FLAG M2

characteristic: antibody

text: SIGMA

text: 4-SU / 365 nm

characteristic: genotype/variation

text: Homo sapiens

text: HEK293, CstF-64tau CLIP

text: PAR-CLIP CstF-64tau


text: live

text: Generic

characteristic: antibody catalog number

characteristic: antibody lot number

text: Bethyl

text: 4-SU / 365 nm

text: Homo sapiens

text: HEK293, CstF-64tau CLIP

text: PAR-CLIP CstF-64tau rep B


text: The Francis Crick Institute

text: live

text: Generic

text: Abcam

characteristic: antibody vendor

characteristic: chip antibody

text: Mus musculus

text: Liver tissue

characteristic: strain

characteristic: time point

text: Liver

characteristic: tissue


characteristic: External Id

text: The Francis Crick Institute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: Abcam

text: Mus musculus

text: Wild Type MEF

text: Wild Type MEF


text: The Francis Crick Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Abcam

text: Mus musculus

text: Mll3∆/∆ MEF

text: Mll3∆/∆ MEF


text: The Francis Crick Institute

text: live

text: Generic

characteristic: SRA accession

text: Mus musculus

characteristic: organism

text: Liver tissue

text: Liver

characteristic: title


text: Ramin Shiekhattar, Gene Expression and Regulation, The Wistar Institute

text: live

text: Generic

text: non-tumorigenic epithelial cell line MCF 10A

characteristic: cell line

text: anti-SNAPC1 rabbit polyclonal (SIGMA, S4950)

text: Homo sapiens


text: live

text: Generic

text: anti-SNAPC 190 (SNAAD17A) mouse monoclonal (Santa Cruz, sc-81379)

text: Homo sapiens


text: live

text: Generic

text: anti-RNAPII N-20 rabbit polyclonal (Santa Cruz, sc899)

text: Homo sapiens

text: RNAPII


text: live

text: Generic

text: normal rabbit IgG (Santa Cruz, sc2027)

text: Homo sapiens

text: IgG


text: live

text: Generic

text: Homo sapiens

text: Chlamydia trachomatis E infected Homo sapiens Hela cells 8b_1_mock_Hep2_rRNAdepl


text: live

text: Generic

text: Generic

characteristic: biosamplemodel

text: Homo sapiens

characteristic: taxon id

text: Chlamydia trachomatis E infected Homo sapiens Hela cells 9a_24_CtE_Hep2_rRNAdepl


SK01600 Germline

text: Genome Information Sciences

text: live

text: Generic

text: Generic

text: normal tissue from Glioblastoma multiforme patient SK01600

characteristic: description

text: GBM; Glioblastoma multiforme

characteristic: disease

text: Homo sapiens

characteristic: subject id

text: germline


SK01600 Primary Tumor

characteristic: External Id

text: Genome Information Sciences

text: live

text: Generic

text: Homo sapiens

text: SK01600 Primary Tumor DNA


SK01600 Tumor Model (Neurospheres)

text: Genome Information Sciences

characteristic: INSDC center name

text: live

text: Generic

text: Homo sapiens

text: SK01600 Tumor Model (Neurospheres)


SK00115 Germline

text: Genome Information Sciences

characteristic: INSDC first public

text: live

text: Generic

text: Homo sapiens

text: SK00115 Germline DNA


SK00115 Primary Tumor

text: Genome Information Sciences

characteristic: INSDC last update

text: live

text: Generic

text: Homo sapiens

text: SK00115 Primary Tumor DNA


SK00115 Tumor Model (Cell Culture)

text: Genome Information Sciences

characteristic: INSDC secondary accession

text: live

text: Generic

text: Homo sapiens

text: SK00115 Tumor Model (Cell Culture) DNA


SK00102 Germline

text: Genome Information Sciences

text: live

characteristic: INSDC status

text: Generic

text: Homo sapiens

text: SK00102 Germline DNA


SK00102 Primary Tumor

text: Genome Information Sciences

text: live

text: Generic

characteristic: NCBI submission model

text: Homo sapiens

text: SK00102 Primary Tumor DNA


SK00102 Tumor Model (Xenograft)

text: Genome Information Sciences

text: live

text: Generic

characteristic: NCBI submission package

text: Homo sapiens

text: SK00102 Tumor Model (Xenograft) DNA


SK00072 Germline

text: Genome Information Sciences

text: live

text: Generic

characteristic: SRA accession

text: Homo sapiens

text: SK00072 Germline DNA


SK00072 Primary Tumor

text: Genome Information Sciences

text: live

text: Generic

text: Homo sapiens

characteristic: organism

text: SK00072 Primary Tumor DNA


SK00072 Tumor Model (Xenograft)

text: Genome Information Sciences

text: live

text: Generic

text: Homo sapiens

text: SK00072 Tumor Model (Xenograft) DNA

characteristic: title


text: Moose Maize Functional Genomics Lab, Department of Crop Sciences, University of Illinois at Urbana-Champaign

text: live

text: Generic

text: 11 days after sowing (3-4 leaf stage)

characteristic: developmental stage

characteristic: genotype

text: Zea mays

text: seedling shoot apex, B73

text: shoot apex

characteristic: tissue

text: Small RNAs from B73 shoot apex - 2007 expt


text: live

text: Generic

text: 11 days after sowing (3-4 leaf stage)

text: Zea mays

text: seedling shoot apex, Mo17

text: shoot apex

text: Small RNAs from Mo17 shoot apex - 2007 expt


text: live

text: Generic

text: 11 days after sowing (3-4 leaf stage)

text: Zea mays

text: seedling shoot apex, B73xMo17

text: shoot apex

text: Small RNAs from B73xMo17 shoot apex - 2007 expt


text: live

text: Generic

text: 11 days after sowing (3-4 leaf stage)

text: Zea mays

text: seedling shoot apex, Mo17xB73

text: shoot apex

text: Small RNAs from Mo17xB73 shoot apex - 2007 expt


text: live

text: Generic

text: 14 days after sowing (3-4 leaf stage)

text: Zea mays

text: seedling shoot apex, B73

text: shoot apex

text: Small RNAs from B73 shoot apex - 2011 expt


text: live

text: Generic

text: 14 days after sowing (3-4 leaf stage)

text: Zea mays

text: seedling shoot apex, Mo17

text: shoot apex

text: Small RNAs from Mo17 shoot apex - 2011 expt


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, B73

text: developing ear

text: Small RNAs from B73 developing ear - high N


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, Mo17

text: developing ear

text: Small RNAs from Mo17 developing ear - high N


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, B73xMo17

text: developing ear

text: Small RNAs from B73xMo17 developing ear - high N


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, B73

text: developing ear

text: Small RNAs from B73 developing ear - low N


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, Mo17

text: developing ear

text: Small RNAs from Mo17 developing ear - low N


text: live

text: Generic

text: V12 growth stage

text: Zea mays

text: female inflorescence, B73xMo17

text: developing ear

text: Small RNAs from B73xMo17 developing ear - low N


text: Huazhong Agricultural University

text: live

text: Generic

text: Valencia

characteristic: cultivar

text: The cDNA library was constructed following the SMART IVTM cDNA Libraty Construction kit (Clontech, Palo Alto, CA, USA).

characteristic: description

text: embryonic callus preserved on MT medium

characteristic: dev-stage

text: Citrus sinensis

text: hermaphrodite

characteristic: sex

text: embryonic callus

characteristic: tissue-type

text: Valenica sweet orange (Citrus sinensis L.Osb) embryonic callus cDNA library

text: pDNR-LIB

characteristic: vector


characteristic: External Id

text: University of Melbourne

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: Staphylococcus aureus


Control

text: Korea Polar Research Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: RNA extracted from control samples grown at 16*C and LD(16L:8D) cycle

text: Deschampsia antarctica

text: Control


Cold

text: Korea Polar Research Institute

text: live

text: Generic

characteristic: SRA accession

text: RNA extracted from cold-treated samples (4*C, 24hrs)

text: Deschampsia antarctica

characteristic: organism

text: Cold

characteristic: title


PEG

text: Korea Polar Research Institute

text: live

text: Generic

text: RNA extracted from dehytrated samples (30%PEG, 24hrs)

text: Deschampsia antarctica

text: PEG


NaCl

text: Korea Polar Research Institute

text: live

text: Generic

text: RNA extracted sample treated with high salinity (300mM NaCl, 24hrs)

text: Deschampsia antarctica

text: NaCl


S. cerevisiae msh2_1

text: Teagasc

text: live

text: Generic

text: Saccharomyces cerevisiae Y06240 (BY4741; Mat a; his3D1; leu2D0; met15D0; ura3D0; msh2::kanMX4) lineage 1

text: Saccharomyces cerevisiae

text: Saccharomyces cerevisiae msh2_1


text: Institute for Genome Sciences University of MD School of Medicine

text: live

text: Generic

text: Homo sapiens

text: Chlamydia trachomatis E infected Homo sapiens Hela cells 9b_24_mock_Hep2_rRNAdepl


text: live

text: Generic

text: Chlamydia psittaci 01DC11

characteristic: strain

text: Chlamydia psittaci 01DC11


text: live

text: Generic

text: Chlamydia psittaci 02DC14

text: Chlamydia psittaci 02DC14


text: live

text: Generic

text: Chlamydia psittaci 02DC15

text: Chlamydia psittaci 02DC15


text: Vanderbilt University

text: live

text: Generic

text: All the mosquito samples used in the present work were 3-5 day post-emergence female An. albimanus of the white-stripe strain obtained from the insectary of the National Institute of Public Health (INSP) in Cuernavaca, Mexico. Mosquitoes were fed with 10 % sucrose ad libitum and reared in a 12:12 hr light cycle maintained at 28*C and 80 % relative humidity. Mosquito infections with P. vivax VK210 and extraction of midgut epithelium of 24 hours and seven days after an infectious blood meal were performed as described [66] in the insectary of the Centro Regional de Investigaci*n en Salud P*blica (CRISP) in Tapachula, Chiapas, Mexico, according to Institute ethical guidelines and approval. Total RNA from 50 An. albimanus midguts was extracted using TRIzol (Life Technologies), DNased and cleaned with an RNeasy column (Qiagen) according to the manufacturer’s instructions. Total RNA was then quality controlled for integrity on a Bioanalyzer (Agilent Technologies). mRNA libraries were constructed and sequenced, as previously described [72-74] on a single lane of a Illumina HiSeq 2000, which generated ~210 million 101 bp paired end reads.

characteristic: description

text: Anopheles albimanus

text: Anopheles albimanus female


text: live

text: Generic

text: Chlamydia psittaci 02DC16

text: Chlamydia psittaci 02DC16


text: live

text: Generic

text: Chlamydia psittaci 02DC18

text: Chlamydia psittaci 02DC18


text: live

text: Generic

text: Chlamydia psittaci 02DC21

text: Chlamydia psittaci 02DC21


text: live

text: Generic

text: Chlamydia psittaci 02DC23

text: Chlamydia psittaci 02DC23


text: live

text: Generic

text: Chlamydia psittaci 02DC22

text: Chlamydia psittaci 02DC22


text: live

text: Generic

text: Chlamydia psittaci 03DC29

text: Chlamydia psittaci 03DC29


text: live

text: Generic

text: Chlamydia psittaci 02DC24

text: Chlamydia psittaci 02DC24


text: live

text: Generic

text: Chlamydia psittaci 04DC42

text: Chlamydia psittaci 04DC42


text: live

text: Generic

text: Chlamydia psittaci 08-2626_L3

text: Chlamydia psittaci 08-2626_L3


text: live

text: Generic

text: Chlamydia psittaci 08DC60

text: Chlamydia psittaci 08DC60


text: live

text: Generic

text: Chlamydia psittaci 09DC77

text: Chlamydia psittaci 09DC77


text: live

text: Generic

text: Chlamydia psittaci 09DC78

text: Chlamydia psittaci 09DC78


text: live

text: Generic

text: Chlamydia psittaci 09DC80

text: Chlamydia psittaci 09DC80


text: live

text: Generic

text: Chlamydia psittaci 09DC79

text: Chlamydia psittaci 09DC79


text: live

text: Generic

text: Chlamydia psittaci 84-8471/1

text: Chlamydia psittaci 84-8471/1


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

characteristic: gender

text: wIR

characteristic: genotype/variation

text: Drosophila melanogaster

text: female fly head, wIR

text: head

characteristic: tissue

text: Small RNA from female fly head of wIR


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO; loqs-PA/TM3

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PA/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PA/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO; loqs-PB/TM3

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PB/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PB/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO; loqs-PA, loqs-PB/TM3

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PA, loqs-PB/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PA, loqs-PB/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO; loqs-PA, loqs-PD/TM3

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PA, loqs-PD/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PA, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO; loqs-PB, loqs-PD/TM3

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PB, loqs-PD/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PB, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO; loqs-PA, loqs-PB, loqs-PD/TM3

text: head

text: Small RNA from female fly head of wIR: loqsKO; loqs-PA, loqs-PB, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsKO/CyO

text: Drosophila melanogaster

text: female fly head, wIR: loqsKO/CyO

text: head

text: Small RNA from female fly head of wIR: loqsKO/CyO


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsf00791

text: Drosophila melanogaster

text: female fly head, wIR: loqsf00791

text: head

text: Small RNA from female fly head of wIR: loqsf00791


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: wIR: loqsf00791/CyO

text: Drosophila melanogaster

text: female fly head, wIR: loqsf00791/CyO

text: head

text: Small RNA from female fly head of wIR: loqsf00791/CyO


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: Drosophila melanogaster

text: fly ovary, w1118

text: ovary

text: Small RNA from fly ovary of w1118


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO; loqs-PA/TM3

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PA/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PA/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO; loqs-PB/TM3

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PB/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PB/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO; loqs-PA, loqs-PB/TM3

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PA, loqs-PB/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PA, loqs-PB/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO; loqs-PA, loqs-PD/TM3

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PA, loqs-PD/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PA, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO; loqs-PB, loqs-PD/TM3

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PB, loqs-PD/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PB, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO; loqs-PA, loqs-PB, loqs-PD/TM3

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO; loqs-PA, loqs-PB, loqs-PD/TM3


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsKO/CyO

text: Drosophila melanogaster

text: fly ovary, w1118: loqsKO/CyO

text: ovary

text: Small RNA from fly ovary of w1118: loqsKO/CyO


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsf00791

text: Drosophila melanogaster

text: fly ovary, w1118: loqsf00791

text: ovary

text: Small RNA from fly ovary of w1118: loqsf00791


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: female

text: w1118: loqsf00791/CyO

text: Drosophila melanogaster

text: fly ovary, w1118: loqsf00791/CyO

text: ovary

text: Small RNA from fly ovary of w1118: loqsf00791/CyO


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: wild-type

text: Mus musculus

text: mouse embryonic fibroblast, wild-type

text: mouse embryonic fibroblasts (MEFs)

text: Small RNA from wild-type mouse embryonic fibroblast


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: PACT-/-

text: Mus musculus

text: mouse embryonic fibroblast, PACT-/-

text: mouse embryonic fibroblasts (MEFs)

text: Small RNA from PACT-/- mouse embryonic fibroblast


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: TRBP-/+

text: Mus musculus

text: mouse tail fibroblast, TRBP-/+

text: mouse tail fibroblasts

text: Small RNA from TRBP-/+ mouse tail fibroblast


text: Zamore, BMP, Umass Medical School

text: live

text: Generic

text: TRBP-/-

text: Mus musculus

text: mouse tail fibroblast, TRBP-/-

text: mouse tail fibroblasts

text: Small RNA from TRBP-/- mouse tail fibroblast


text: Victor Corces, Biology, Emory University

text: live

text: Generic

text: Kc167 Drosophila Embryonic Cell line

characteristic: cell type

text: H3K27me3 Millipore Cat. # 07-449 Lot # JBC1924326

characteristic: chip antibody

text: Drosophila melanogaster

text: Kc cells


characteristic: External Id

text: Institute for Genome Sciences University of MD School of Medicine

characteristic: INSDC center name

text: live

text: Generic

text: Chlamydia psittaci 99DC5

text: Chlamydia psittaci 99DC5


characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: Chlamydia psittaci C1/97

text: Chlamydia psittaci C1/97


characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: Chlamydia psittaci C19/98

text: Chlamydia psittaci C19/98


text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: Chlamydia psittaci C6/98

text: Chlamydia psittaci C6/98


text: modENCODE DCC, Ontario Institute for Cancer Research

text: live

text: Generic

characteristic: SRA accession

characteristic: cell line

text: third instar larval stage

characteristic: developmental stage

text: y v f mal

characteristic: genotype

text: Drosophila melanogaster

characteristic: organism

text: female

characteristic: sex

text: ML-DmD16-c3 (Celniker/RNA:133)

text: dorsal mesothoracic disc

text: ML-DmD16-c3 (Celniker/RNA:133) extraction1_seq1 aliquote 1


text: live

text: Generic

text: third instar larval stage

text: y v f mal

text: Drosophila melanogaster

text: male

text: ML-DmD20-c5 (Celniker/RNA:191)

text: antenna disc-derived cell-line

characteristic: tissue

text: ML-DmD20-c5 (Celniker/RNA:191) extraction1_seq1 aliquote 1

characteristic: title


text: live

text: Generic

text: third instar larval stage

text: y v f mal

text: Drosophila melanogaster

text: male

text: ML-DmD20-c5 (Celniker/RNA:187)

text: antenna disc-derived cell-line

text: ML-DmD20-c5 (Celniker/RNA:187) extraction1_seq1 aliquote 1


text: live

text: Generic

text: late embryonic stage

text: Drosophila melanogaster

text: S1 (Celniker/RNA:25)

text: embryo-derived cell-line

text: S1 (Celniker/RNA:25) extraction1_seq1 aliquote 1


text: live

text: Generic

text: late embryonic stage

text: Drosophila melanogaster

text: male

text: embryo-derived cell-line

text: Lai_DTT-4h extraction1_seq1 aliquote 1


text: live

text: Generic

text: third instar larval stage

text: y v f mal

text: Drosophila melanogaster

text: ML-DmD8 (Celniker/RNA:205)

text: dorsal mesothoracic disc

text: ML-DmD8 (Celniker/RNA:205) extraction1_seq1 aliquote 1


text: live

text: Generic

text: third instar larval stage

text: y v f mal

text: Drosophila melanogaster

text: ML-DmD8 (Celniker/RNA:207)

text: dorsal mesothoracic disc

text: ML-DmD8 (Celniker/RNA:207) extraction1_seq1 aliquote 1


text: live

text: Generic

text: late embryonic stage

text: l(2)malignant blood neoplasm

text: Drosophila melanogaster

text: mbn2 (Celniker/RNA:47)

text: embryonic/larval hemocyte

text: mbn2 (Celniker/RNA:47) extraction1_seq1 aliquote 1


text: live

text: Generic

text: late embryonic stage

text: l(2)malignant blood neoplasm

text: Drosophila melanogaster

text: mbn2 (Celniker/RNA:43)

text: embryonic/larval hemocyte

text: mbn2 (Celniker/RNA:43) extraction1_seq1 aliquote 1


text: live

text: Generic

text: CME W2

text: third instar larval stage

text: Drosophila melanogaster

text: CME-W2 (Celniker/RNA:459)

text: dorsal mesothoracic disc

text: CME-W2 (Celniker/RNA:459) extraction1_seq1 aliquote 1


text: live

text: Generic

text: CME W2

text: third instar larval stage

text: Drosophila melanogaster

text: CME-W2 (Celniker/RNA:461)

text: dorsal mesothoracic disc

text: CME-W2 (Celniker/RNA:461) extraction1_seq1 aliquote 1


text: CSISP

text: live

text: Generic

text: Experiment1. Ileum content from untreated B6 mouse obtained from The Jacskon laboratory.

characteristic: description

text: mouse gut metagenome


characteristic: External Id

text: CSISP

text: live

text: Generic

text: Experiment1. Ileum content from a mouse that received an allogenic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

characteristic: INSDC center name

text: live

text: Generic

text: Experiment1. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

characteristic: INSDC first public

text: live

text: Generic

text: Experiment1. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model.Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

characteristic: INSDC last update

text: live

text: Generic

text: Experiment1. Ileum content from a mouse that received an syngeneic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

characteristic: INSDC secondary accession

text: live

text: Generic

text: Experiment1. Ileum content from a mouse that received an syngeneic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

characteristic: INSDC status

text: Generic

text: Experiment2. Ileum content from untreated B6 mouse.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

characteristic: NCBI submission model

text: Experiment2. Ileum content from a mouse that received an allogenic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

characteristic: NCBI submission package

text: Experiment2. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

characteristic: SRA accession

text: Experiment2. Ileum content from a mouse that received an syngeneic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment2. Ileum content from a mouse that received an syngeneic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Ileum content from untreated B6 mouse.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Ileum content from a mouse that recevied an allogenic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Ileum content from a mouse that recevied an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Ileum content from a B6 mouse that received an osmotic laxative for 7 days.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Ileum content from a B6 mouse that received DSS for 7 days.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from untreated mouse.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from a mouse that received an allogenic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model.Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from a mouse that received an syngeneic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment1. Cecum content from a mouse that received an syngeneic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Cecum content from untreated B6 mouse.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Cecum content from a mouse that recevied an allogenic bone marrow transplant without T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Cecum content from a mouse that recevied an allogenic bone marrow transplant with T cells, using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Cecum content from a B6 mouse that received an osmotic laxative for 7 days.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment3. Cecum content from a B6 mouse that received DSS for 7 days.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment8. Ileum content from a B6 untreated mouse. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Untreated_ileum_content_1_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_2_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_3_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_4_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_5_D0_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment 8. Ileum content from a B6 mouse that recover for 2 weeks after 7 days of ampicillin treatment.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Ampicillin_ileum_content_1_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_2_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_3_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_4_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_5_D0_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment8. Ileum content from a B6 mouse that recover for 2 weeks after 7 days of ampicillin treatment. Mouse was oral gavage with Lactobacillus during the 2 weeks recovery phase.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_1_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_2_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_3_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_4_D0_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_5_D0_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment8. Ileum content from untreated mouse that received an allogenic bone marrow transplant with T cells using the B10.BR -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Untreated_ileum_content_1_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_2_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_3_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_4_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_5_D14_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment 8. A mouse was treated for 7 days with ampicillin. 2 weeks after stopping antibiotic treatment, the mouse received an allogenic bone marrow transplant with T cells using the B10.BR -&gt; B6 model. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Ampicillin_ileum_content_1_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_2_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_3_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_4_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_5_D14_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment 8. A mouse was treated for 7 days with ampicillin. After stopping antibiotic treatment, the mouse received for 2 weeks Lactobacillus by oral gavage, followed by an allogenic bone marrow transplant with T cells using the B10.BR -&gt; B6 model. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_1_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_2_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_3_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_4_D14_Experiment8


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_5_D14_Experiment8


text: CSISP

text: live

text: Generic

text: Experiment 4. Ileum content from a BM12 untreated mouse. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment4. Ileum content from a mouse that received an allogenic bone marrow transplant without T cells, using the B6 -&gt; BM12 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment4. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B6 -&gt; BM12 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment 5. Ileum content from a BM12 untreated mouse. Mouse obtained from The Jackson laboratory. (2nd Experiment)

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment 5. Ileum content from a BM12 untreated mouse. Mouse obtained from The Jackson laboratory.(2nd Experiment)

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment5. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B6 -&gt; BM12 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.(2nd Experiment)

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment6. Ileum content from an untreated B10. BR mouse. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment6. Ileum content from a mouse that received an allogenic bone marrow transplant without T cells, using the B6 -&gt; B10.BR model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment6. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the B6 -&gt; B10.BR model. Samples were obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment7. Ileum content from an untreated B6 mouse. Mouse obtained from the Charles River laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment7. Ileum content from a mouse that received an allogenic bone marrow transplant without T cells, using the BALBc -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from Charles River laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment7. Ileum content from a mouse that received an allogenic bone marrow transplant with T cells, using the BALBc -&gt; B6 model. Samples were obtained 2 weeks after the transplant. Mouse obtained from Charles River laboratory.

text: mouse gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 with GVHD. Fecal sample obtained 9 days before allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 with GVHD. Fecal sample obtained the day of the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 with GVHD. Fecal sample obtained 12 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 with GVHD. Fecal sample obtained 18 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 2 days before allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 5 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 16 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 17 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 27 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 with GVHD. Fecal sample obtained 32 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 with GVHD. Fecal sample obtained 3 days before allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 with GVHD. Fecal sample obtained 1 day after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 with GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 with GVHD. Fecal sample obtained 16 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 with GVHD. Fecal sample obtained 21 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 1 day before allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 6 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 13 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 20 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 41 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 50 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 129 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 154 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 335 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 340 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 with GVHD. Fecal sample obtained 342 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 1 day before allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 18 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 21 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 29 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 with GVHD. Fecal sample obtained 57 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 with GVHD. Fecal sample obtained 2 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 with GVHD. Fecal sample obtained 9 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 with GVHD. Fecal sample obtained 12 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 with GVHD. Fecal sample obtained 20 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 8 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained the day of the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 14 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 34 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 42 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 with GVHD. Fecal sample obtained 91 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 with GVHD. Fecal sample obtained the day of the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 with GVHD. Fecal sample obtained 8 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 with GVHD. Fecal sample obtained 16 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 with GVHD. Fecal sample obtained 22 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 with GVHD. Fecal sample obtained 29 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 non-GVHD. Fecal sample obtained 2 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 non-GVHD. Fecal sample obtained 6 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 non-GVHD. Fecal sample obtained 12 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 non-GVHD. Fecal sample obtained 24 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 1 non-GVHD. Fecal sample obtained 26 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 10 non-GVHD. Fecal sample obtained 2 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 10 non-GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 10 non-GVHD. Fecal sample obtained 15 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 10 non-GVHD. Fecal sample obtained 22 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 non-GVHD. Fecal sample obtained 7 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 non-GVHD. Fecal sample obtained the day of the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 non-GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 non-GVHD. Fecal sample obtained 14 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 2 non-GVHD. Fecal sample obtained 51 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 non-GVHD. Fecal sample obtained 1 day before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 non-GVHD. Fecal sample obtained 6 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 3 non-GVHD. Fecal sample obtained 19 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 8 day before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained the day of the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 7 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 18 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 25 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 28 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 4 non-GVHD. Fecal sample obtained 35 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 non-GVHD. Fecal sample obtained 5 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 non-GVHD. Fecal sample obtained 2 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 non-GVHD. Fecal sample obtained 9 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 5 non-GVHD. Fecal sample obtained 18 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 2 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 6 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 12 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 19 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 22 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 26 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 33 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 6 non-GVHD. Fecal sample obtained 42 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 non-GVHD. Fecal sample obtained 6 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 non-GVHD. Fecal sample obtained 11 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 non-GVHD. Fecal sample obtained 21 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 non-GVHD. Fecal sample obtained 56 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 7 non-GVHD. Fecal sample obtained 379 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 non-GVHD. Fecal sample obtained 1 day before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 non-GVHD. Fecal sample obtained 5 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 non-GVHD. Fecal sample obtained 13 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 non-GVHD. Fecal sample obtained 19 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 8 non-GVHD. Fecal sample obtained 26 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 13 days before the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 2 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 13 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 19 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 26 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 28 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 30 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 33 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 42 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Patient 9 non-GVHD. Fecal sample obtained 49 days after the allogenic bone marrow transplant.

text: human gut metagenome


text: CSISP

text: live

text: Generic

text: Experiment9. Ileum content from a BM12 untreated mouse. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Untreated_ileum_content_1_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_2_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_3_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_4_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Untreated_ileum_content_5_D0_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. Ileum content from a BM12 mouse that recover for 2 weeks after 7 days of ampicillin treatment.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Ampicillin_ileum_content_1_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_2_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_3_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_4_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_5_D0_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. Ileum content from a BM12 mouse that recover for 2 weeks after 7 days of ampicillin treatment. Mouse was oral gavage with Lactobacillus during the 2 weeks recovery phase.Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_1_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_2_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_3_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_4_D0_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_5_D0_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. A mouse was treated for 7 days with ampicillin. 2 weeks after stopping antibiotic treatment, the mouse received an allogenic bone marrow transplant with T cells using the B6 -&gt; BM12 model. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Ampicillin_ileum_content_1_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_2_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_3_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_4_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Ampicillin_ileum_content_5_D14_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. A mouse was treated for 7 days with ampicillin. After stopping antibiotic treatment, the mouse received for 2 weeks Lactobacillus by oral gavage, followed by an allogenic bone marrow transplant with T cells using the B6 -&gt; BM12 model. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_1_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_2_D14_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_3_D14_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. A mouse was treated for 7 days with ampicillin. After stopping antibiotic treatment, the mouse received for 2 weeks Lactobacillus by oral gavage, followed by an allogenic bone marrow transplant with T cells using the ABM Rag1 KO TCR -&gt; BM12 model. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_1_ABM_D14_Experiment9


text: CSISP

text: live

text: Generic

text: Experiment9. A mouse was treated for 7 days with ampicillin. After stopping antibiotic treatment, the mouse received for 2 weeks Lactobacillus by oral gavage, followed by an allogenic bone marrow transplant with T cells using the ABM Rag1 KO TCR -&gt; BM12 modell. The content from the ileum was obtained 2 weeks after the transplant. Mouse obtained from The Jackson laboratory.

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_2_D14_ABM_Experiment9


text: CSISP

text: live

text: Generic

text: mouse gut metagenome

text: Amp+Lactobacillus_ileum_content_3_D14_ABM_Experiment9


name: Salmonella enterica subsp. enterica serovar Bareilly str. CFSAN000190

text: crustaceans

characteristic: IFSAC Category

text: Food and Drug Administration, Center for Food Safety and Applied Nutrition

text: live

text: Pathogen.env

text: Generic

characteristic: biosamplemodel

characteristic: fda lab id

text: frozen raw peeled shrimp

characteristic: isolation source

text: shrimp (frozen):FOODON_03301169, shrimp (peeled, raw):FOODON_03308626

characteristic: ontological term

text: Bareilly

characteristic: serovar

text: Food

characteristic: source type

characteristic: strain

text: enterica

characteristic: sub species


name: Salmonella enterica subsp. enterica serovar Bareilly str. CFSAN000192

characteristic: External Id

text: crustaceans

characteristic: INSDC center name

text: live

text: Pathogen.env

text: Generic

text: frozen crab claw

text: frozen:PATO_0001985, crab claw:FOODON_00002677

characteristic: organism

text: Bareilly

text: Food

text: enterica

characteristic: title


text: National Research Center

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

text: Oocyte

characteristic: cell type

text: Bubalus bubalis

text: female

characteristic: sex

text: Partial mRNA sequence isolated from Bubalus bubalis in vitro matured oocytes using differential display technique


text: dbGaP

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: DNA

characteristic: analyte type

characteristic: biospecimen repository

characteristic: biospecimen repository sample id

text: PBCRC

text: SNP Genotypes (Array)

characteristic: molecular data type

text: Homo sapiens

text: female

text: Case-Control

characteristic: study design

text: Italian PBC Study

characteristic: study name

text: No

characteristic: subject is affected

characteristic: submitted sample id

characteristic: submitted subject id

characteristic: submitter handle

text: DNA sample from a human female participant in the dbGaP study Italian PBC Study


characteristic: External Id

text: dbGaP

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: DNA

text: PBCRC

text: SNP Genotypes (Array)

text: Homo sapiens

characteristic: organism

text: male

text: Case-Control

text: Italian PBC Study

text: No

text: DNA sample from a human male participant in the dbGaP study Italian PBC Study

characteristic: title


text: dbGaP

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: DNA

text: PBCRC

text: SNP Genotypes (Array)

text: Homo sapiens

text: female

characteristic: sex

text: Case-Control

text: Liver Cirrhosis, Biliary

characteristic: study disease

text: Italian PBC Study

text: Yes


text: dbGaP

text: live

text: Generic

characteristic: NCBI submission package

text: DNA

characteristic: analyte type

characteristic: biospecimen repository

characteristic: biospecimen repository sample id

text: PBCRC

text: SNP Genotypes (Array)

characteristic: molecular data type

text: Homo sapiens

text: male

text: Case-Control

text: Liver Cirrhosis, Biliary

text: Italian PBC Study

text: Yes


text: dbGaP

text: live

text: Generic

text: DNA

text: PBCRC

text: SNP Genotypes (Array)

text: Homo sapiens

text: Case-Control

characteristic: study design

text: Italian PBC Study

characteristic: study name

text: No

characteristic: subject is affected

characteristic: submitted sample id

characteristic: submitted subject id

text: DNA sample from a human participant in the dbGaP study Italian PBC Study


characteristic: External Id

text: KRIBB, KOBIC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: Homo sapiens

characteristic: organism

text: A high dimensional deep sequencing study of non-small cell lung adenocarcinoma in never-smoker Korean females


text: Statistics, Stanford

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: clutch

text: stage 9

characteristic: developmental stage

text: Xenopus tropicalis

text: embryo_stage 9

text: Outbred

characteristic: strain

text: embryo

characteristic: tissue

characteristic: title


text: Statistics, Stanford

text: live

text: Generic

characteristic: NCBI submission package

text: stage 10

text: Xenopus tropicalis

text: embryo_stage 10

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 11-12

text: Xenopus tropicalis

text: embryo_stage 11-12

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 15

text: Xenopus tropicalis

text: embryo_stage 15

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 16-18

text: Xenopus tropicalis

text: embryo_stage 16-18

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 19

text: Xenopus tropicalis

text: embryo_stage 19

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 20-21

text: Xenopus tropicalis

text: embryo_stage 20-21

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 22-23

text: Xenopus tropicalis

text: embryo_stage 22-23

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 24-26

text: Xenopus tropicalis

text: embryo_stage 24-26

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 28

text: Xenopus tropicalis

text: embryo_stage 28

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 31-32

text: Xenopus tropicalis

text: embryo_stage 31-32

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 33-34

text: Xenopus tropicalis

text: embryo_stage 33-34

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 40

text: Xenopus tropicalis

text: embryo_stage 40

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 41-42

text: Xenopus tropicalis

text: embryo_stage 41-42

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: Xenopus tropicalis

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 6

text: Xenopus tropicalis

text: embryo_stage 6

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 8

text: Xenopus tropicalis

text: embryo_stage 8

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 9

text: Xenopus tropicalis

text: embryo_stage 9

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 10

text: Xenopus tropicalis

text: embryo_stage 10

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 11-12

text: Xenopus tropicalis

text: embryo_stage 11-12

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 13-14

text: Xenopus tropicalis

text: embryo_stage 13-14

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 16-18

text: Xenopus tropicalis

text: embryo_stage 16-18

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 19

text: Xenopus tropicalis

text: embryo_stage 19

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 20-21

text: Xenopus tropicalis

text: embryo_stage 20-21

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 22-23

text: Xenopus tropicalis

text: embryo_stage 22-23

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 24-26

text: Xenopus tropicalis

text: embryo_stage 24-26

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 28

text: Xenopus tropicalis

text: embryo_stage 28

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 31-32

text: Xenopus tropicalis

text: embryo_stage 31-32

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 33-34

text: Xenopus tropicalis

text: embryo_stage 33-34

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 38-39

text: Xenopus tropicalis

text: embryo_stage 38-39

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 40

text: Xenopus tropicalis

text: embryo_stage 40

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 41-42

text: Xenopus tropicalis

text: embryo_stage 41-42

text: Outbred

text: embryo


text: Statistics, Stanford

text: live

text: Generic

text: stage 44-45

text: Xenopus tropicalis

text: embryo_stage 44-45

text: Outbred

text: embryo


text: Whitehead Institute for Biomedical Research

text: live

text: Generic

text: 24 hours post fertilization

text: wild type

characteristic: genotype/variation

text: Danio rerio

text: whole embryo at 24 hours post fertilization

text: whole embryo


text: live

text: Generic

text: 72 hours post fertilization

text: wild type

text: Danio rerio

text: whole embryo at 72 hours post fertilization

text: whole embryo


text: live

text: Generic

text: adult

text: wild type

text: Danio rerio

text: mixed gender adults

text: whole adult


text: live

text: Generic

text: 1.5-2 hours post fertilization

text: wild type

text: Danio rerio

text: whole embryo at 1.5-2 hours post fertilization

text: whole embryo


text: live

text: Generic

text: 6 hours post fertilization

text: wild type

text: Danio rerio

text: whole embryo at 6 hours post fertilization

text: whole embryo


text: live

text: Generic

text: adult

text: wild type

text: Danio rerio

text: mixed gender adults

text: brain


text: live

text: Generic

text: adult

text: wild type

text: Danio rerio

text: female adults

text: ovary


text: live

text: Generic

text: adult

text: wild type

text: Danio rerio

text: male adults

text: testis


text: live

text: Generic

text: 1 cell stage

text: wild type

text: Danio rerio

text: whole embryo at 1 cell stage

text: whole embryo


text: live

text: Generic

text: 4 hours post fertilization

text: wild type

text: Danio rerio

text: whole embryo at 4 hours post fertilization

text: whole embryo


text: BGI

text: live

text: Generic

text: 3 years old

characteristic: age

text: female

characteristic: gender

text: Yunnan black goat

characteristic: landrace

text: Capra hircus

text: Bladder

text: Bladder

text: Bladder tissue from female Yunnan black goat


characteristic: External Id

text: BGI

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Brain

text: Brain

text: Brain tissue from female Yunnan black goat


text: BGI

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

characteristic: organism

text: Heart

text: Heart

text: Heart tissue from female Yunnan black goat


text: BGI

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Kidney

text: Kidney

text: Kidney tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Liver

text: Liver

text: Liver tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Lung

text: Lung

text: Lung tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Lymph

text: Lymph

text: Lymph tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Muscle

text: Muscle

text: Muscle tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Ovarian

text: Ovarian

text: Ovarian tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: 3 years old

text: female

text: Yunnan black goat

text: Capra hircus

text: Spleen

text: Spleen

text: Spleen tissue from female Yunnan black goat


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Secondary hair folicle From individual A

text: Secondary hair folicle

text: Secondary hair folicle from Inner Mongolia cashmere goat (individual A)


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Secondary hair folicle From individual B

text: Secondary hair folicle

text: Secondary hair folicle from Inner Mongolia cashmere goat (individual B)


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Secondary hair folicle From individual C

text: Secondary hair folicle

text: Secondary hair folicle from Inner Mongolia cashmere goat (individual C)


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Primary hair folicle From individual A

text: Primary hair folicle

text: Primary hair folicle from Inner Mongolia cashmere goat (individual A)


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Primary hair folicle From individual B

text: Primary hair folicle

text: Primary hair folicle from Inner Mongolia cashmere goat (individual B)


text: BGI

text: live

text: Generic

text: Inner Mongolia cashmere goat

text: Capra hircus

text: Primary hair folicle From individual C

text: Primary hair folicle

text: Primaryhair folicle from Inner Mongolia cashmere goat (individual C)


name: Salmonella enterica subsp. enterica serovar Bareilly str. CFSAN000181

text: other (food additive)

characteristic: IFSAC Category

text: Food and Drug Administration, Center for Food Safety and Applied Nutrition

text: live

text: Pathogen.env

text: Generic

characteristic: biosamplemodel

text: gum arabic

characteristic: isolation source

text: gum arabic:FOODON_03412975

characteristic: ontological term

text: Bareilly

characteristic: serovar

text: Food

characteristic: source type

characteristic: strain

text: enterica

characteristic: sub species


characteristic: External Id

text: Weill Cornell Medical College

text: live

text: Generic

characteristic: NCBI submission package

text: colon cancer

characteristic: cell type

text: Homo sapiens

text: Colon cancer derived cell line

text: HCT116 cell line

characteristic: tissue type

text: HCT116 5ng_Rep#1

characteristic: title


text: Weill Cornell Medical College

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: colon cancer

text: Homo sapiens

characteristic: organism

text: Colon cancer derived cell line

text: HCT116 cell line

text: HCT116 5ng_Rep#2


text: Weill Cornell Medical College

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: colon cancer

text: Homo sapiens

text: Colon cancer derived cell line

text: HCT116 cell line

text: HCT116 50ng


text: Weill Cornell Medical College

text: live

text: Generic

text: colon cancer

text: Homo sapiens

text: Colon cancer derived cell line

text: HCT116 cell line

text: HCT116 50ng_ERRBS


text: Weill Cornell Medical College

text: live

text: Generic

text: colon cancer

text: Homo sapiens

text: Colon cancer derived cell line

text: HCT116 cell line

text: HCT116 1µg


text: Weill Cornell Medical College

text: live

text: Generic

text: colon cancer

text: Homo sapiens

text: Colon cancer derived cell line

text: DKO cell line

text: DKO


text: Weill Cornell Medical College

text: live

text: Generic

text: CD34+ normal

text: Homo sapiens

text: CD34+ normal bone marrow control

text: bone marrow


text: Weill Cornell Medical College

text: live

text: Generic

text: MLL rearranged Acute Myeloid Leukemia

text: Homo sapiens

text: MLL rearranged Acute Myeloid Leukemia patient sample

text: bone marrow


text: Weill Cornell Medical College

text: live

text: Generic

text: IDH mutated Acute Myeloid Leukemia

text: Homo sapiens

text: IDH mutated Acute Myeloid Leukemia patient sample

text: bone marrow


text: Weill Cornell Medical College

text: live

text: Generic

text: Acute Myeloid Leukemia

text: Homo sapiens

text: Acute Myeloid Leukemia patient sample

text: bone marrow

text: AML


text: Weill Cornell Medical College

text: live

text: Generic

text: Acute Myeloid Leukemia

text: Homo sapiens

text: Acute Myeloid Leukemia patient sample

text: bone marrow


text: ENCODE DCC

text: live

text: Generic

text: immortalized

characteristic: age

text: Immortal cells

characteristic: age description

text: Input

characteristic: antibody

text: Control signal which may be subtracted from experimental raw signal before peaks are called.

characteristic: antibody description

text: Barbara Wold lab

characteristic: biomaterial provider

characteristic: cell

text: Myoblast cell line derived from thigh muscle of C3H mice after crush injury

characteristic: cell description

text: mouse

characteristic: cell organism

text: F

characteristic: cell sex

characteristic: control

text: This data represents a control being compared to experiments using read length of 50 bp

characteristic: control description

characteristic: controlid

text: ChipSeq

characteristic: datatype

text: Chromatin IP Sequencing

characteristic: datatype description

text: Caltech-m

characteristic: lab

text: Wold - Califonia Institute of Technology

characteristic: lab description

characteristic: labexpid

text: Myocyte

characteristic: labversion

text: Myocyte

characteristic: labversion description

text: Mus musculus

characteristic: replicate

text: Strain C3H, Very related to C57BL/6

characteristic: strain description

text: Caltech_ChipSeq_C2C12_Input_Control_50bp_EqS_2.0pct_60hr

characteristic: treatment

text: 60 h with 2.0% Equine Serum and Insulin (Wold)

characteristic: treatment description


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: immortalized

characteristic: age

text: Immortal cells

characteristic: age description

characteristic: antibody

text: rabbit polyclonal. Antibody Target: H3K27me3

characteristic: antibody antibodydescription

text: Histone H3 (tri-methyl K27). Marks promoters that are silenced by Polycomb proteins in a given lineage; large domains are found at inactive developmental loci.

characteristic: antibody targetdescription

characteristic: antibody vendorid

text: Millipore

characteristic: antibody vendorname

text: Barbara Wold lab

characteristic: biomaterial provider

characteristic: cell

characteristic: cell description

text: mouse

text: F

text: This data represents a control being compared to experiments using read length of 32 bp

text: ChipSeq

text: Chromatin IP Sequencing

text: Caltech-m

text: Myoblast

text: Mus musculus

characteristic: organism

characteristic: strain

text: Strain C3H, Very related to C57BL/6

text: Caltech_ChipSeq_C2C12_H3K27me3_Control_32bp

characteristic: title

text: No special treatment or protocol applies


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: immortalized

text: Immortal cells

text: rabbit polyclonal. Antibody Target: H3K36me3

text: Histone H3 (tri-methyl K36). Marks regions of RNAPII elongation, including coding and non-coding transcripts.

text: Abcam

text: Barbara Wold lab

text: mouse

characteristic: cell organism

text: F

characteristic: cell sex

characteristic: control

characteristic: control description

characteristic: controlid

text: ChipSeq

characteristic: datatype

text: Chromatin IP Sequencing

characteristic: datatype description

text: Caltech-m

characteristic: lab

characteristic: lab description

characteristic: labexpid

text: Myocyte

characteristic: labversion

text: Myocyte

characteristic: labversion description

text: Mus musculus

characteristic: replicate

text: Strain C3H, Very related to C57BL/6

characteristic: strain description

text: Caltech_ChipSeq_C2C12_H3K36me3_Control_50bp_EqS_2.0pct_60hr

characteristic: treatment

characteristic: treatment description


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: immortalized

characteristic: age

text: Immortal cells

characteristic: age description

characteristic: antibody

text: Rabbit polyclonal. Antibody Target: H3K79me3

characteristic: antibody antibodydescription

text: Associated with the gene body of actively transcribed genes

characteristic: antibody targetdescription

characteristic: antibody vendorid

text: Abcam

characteristic: antibody vendorname

text: Barbara Wold lab

characteristic: biomaterial provider

characteristic: cell

characteristic: cell description

text: mouse

text: F

text: ChipSeq

text: Chromatin IP Sequencing

text: Caltech-m

text: Myoblast

text: Mus musculus

characteristic: organism

characteristic: strain

text: Strain C3H, Very related to C57BL/6

text: Caltech_ChipSeq_C2C12_H3K79me3_(ab2621)_Control_50bp

characteristic: title


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: immortalized

text: Immortal cells

text: Rabbit polyclonal. Antibody Target: H3K79me2

text: H3K79me2 is a mark of the transcriptional transition region - the region between the initiation marks (K4me3, etc) and the elongation marks (K36me3)

text: Abcam

text: Barbara Wold lab

text: mouse

characteristic: cell organism

text: F

characteristic: cell sex

characteristic: control

characteristic: control description

characteristic: controlid

text: ChipSeq

characteristic: datatype

text: Chromatin IP Sequencing

characteristic: datatype description

text: Caltech-m

characteristic: lab

characteristic: lab description

characteristic: labexpid

text: Myoblast

characteristic: labversion

text: Mus musculus

characteristic: replicate

text: Strain C3H, Very related to C57BL/6

characteristic: strain description

text: Caltech_ChipSeq_C2C12_H3K79me2_(ab3594)_Control_50bp

characteristic: treatment description


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: immortalized

characteristic: age

text: Immortal cells

characteristic: age description

characteristic: antibody

characteristic: antibody antibodydescription

characteristic: antibody targetdescription

characteristic: antibody vendorid

text: Abcam

characteristic: antibody vendorname

text: Barbara Wold lab

characteristic: biomaterial provider

characteristic: cell

text: Myoblast cell line derived from thigh muscle of C3H mice after crush injury

characteristic: cell description

text: mouse

text: F

text: This data represents a control being compared to experiments using read length of 50 bp

text: ChipSeq

text: Chromatin IP Sequencing

text: Caltech-m

text: Wold - Califonia Institute of Technology

text: Myocyte

text: Myocyte

characteristic: labversion description

text: Mus musculus

characteristic: organism

characteristic: strain

text: Strain C3H, Very related to C57BL/6

text: Caltech_ChipSeq_C2C12_H3K79me2_(ab3594)_Control_50bp_EqS_2.0pct_60hr

characteristic: title

characteristic: treatment


characteristic: External Id

text: ENCODE DCC

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: immortalized

text: Immortal cells

text: Rabbit polyclonal. Antibody Target: H3K4me2

text: Histone H3 (di methyl K4). Marks promoters and enhancers.

text: Abcam

text: Barbara Wold lab

text: mouse

characteristic: cell organism

text: F

characteristic: cell sex

characteristic: control

characteristic: control description

characteristic: controlid

text: ChipSeq

characteristic: datatype

text: Chromatin IP Sequencing

characteristic: datatype description

text: Caltech-m

characteristic: lab

characteristic: lab description

characteristic: labexpid

text: Myocyte

characteristic: labversion

text: Myocyte

text: Mus musculus

characteristic: replicate

text: Strain C3H, Very related to C57BL/6

characteristic: strain description

text: Caltech_ChipSeq_C2C12_H3K4me2_(ab32356)_Control_50bp_EqS_2.0pct_60hr

text: 60 h with 2.0% Equine Serum and Insulin (Wold)

characteristic: treatment description